Perseus Biomics

Active Private limited companyfounded 2016active for 10 yearsGaston Geenslaan 3, 3001 LeuvenKBO/BCE: BE 0650.946.412 #5 company by total assets in Flemish Brabant, Pharmaceuticals sector

Perseus Biomics

Follow Report Compare

Holdings

own 2025 accounts, the bar shows equity in euros

This companyPerseus Biomics2 holdings, 2 countries 2025 accounts

Belgium 1 Year Equity Result

BE Chrometra BV50% 2025€27,854 result -€22,351 (2025)

Europe 1 Year Equity Result

PL Perseus Agiome Limited Liability 2024€72,853 result -€524,528 (2024)

Source: list of holdings in its own 2025 accounts. Holdings that file themselves stand with their latest accounts, the others with the amounts of that list, in their own currency.

At the same address

Gaston Geenslaan 3, 3001 Leuven · 13 other companies

Bio-Incubator Leuven establishment since 01-10-2021 · founded in 2005	7 FTE (2025) 0876.605.232
AUGUSTINE THERAPEUTICS registered office since 13-03-2019 · founded in 2019	11 FTE (2025) 0722.705.230
AstriVax Therapeutics registered office since 04-07-2022 · founded in 2022	17 FTE (2025) 0787.990.881
QUOMAK registered office since 30-05-2025 · founded in 1992	9.4 FTE (2025) 0448.488.111
K5 Therapeutics registered office since 02-11-2020 · founded in 2020	18 FTE (2025) 0757.718.072
Montis Biosciences registered office since 15-01-2020 · founded in 2019 · negative equity (2025)	8.2 FTE (2025) 0730.979.429
ReWind Therapeutics registered office since 06-10-2017 · founded in 2017 · negative equity (2025)	4.9 FTE (2025) 0682.626.216
Metaptys registered office since 04-06-2014 · founded in 2014	7.3 FTE (2025) 0554.664.311
NovelYeast establishment since 01-01-2021 · founded in 2019	total assets €968,333 (2025) 0732.508.366
Tavira Therapeutics registered office since 09-06-2023 · founded in 2023 · negative equity (2025)	total assets €863,682 (2025) 0802.591.262

and 3 more

Holdings and subsidiaries

2 holdings

Share, source and own figures per holding (2)

Source for every holding own accounts 2025

Perseus Agiome Limited LiabilityPLsubsidiary
Equity €72,853Result -€524,528

100%
CHROMETRA
Equity €27,854 Loss of €22,351 in 2025 (profit of €4,341 in 2024) Checked score 79

50%

Holdings through the years 2021 to 2025

Holdings through the years
Name	2021	2022	2023	2024	2025
Perseus Agiome Limited LiabilityPL 2022 to 2025: 100%		100%
CHROMETRA 2021 to 2025: 50%	50%

Source: list of holdings in its own accounts

Connections & network

6 current directors

Depth

The network starts from the directors of Perseus Biomics. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet